STOCK TITAN

BlueLinx Holdings Inc. Form 4 Filings

BXC NYSE

Every Form 4 that BlueLinx Holdings Inc. (BXC) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow BXC and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full BXC filings page.

Rhea-AI Summary

BlueLinx Holdings Inc. director Kim S. Fennebresque reported that a grantor trust associated with him sold 34,138 shares of Common Stock of BlueLinx on August 6, 2026. The disposition was reported as an indirect sale by the grantor trust at a weighted average price of $84.15 per share, with individual sale prices ranging from $82.46 to $85.51. After these transactions, Fennebresque is shown as holding 12,982 shares of Common Stock directly, plus several blocks of Restricted Stock Units (RSUs), including a direct RSU award covering 4,266 underlying shares and multiple indirect RSU holdings in the grantor trust with different historical vesting and future delivery schedules.

Rhea-AI Summary

BlueLinx Holdings Inc. Chief Commercial Officer Leonard Alexander Oei reported routine equity compensation activity involving restricted stock units and related tax withholding. On June 6, 2026 and June 7, 2026, time-based restricted stock units vested and were converted into common stock, including 765 units on June 6 and 469 and 133 units on June 7.

To cover tax withholding obligations, a total of 405 common shares were withheld at $50.30 per share across several entries, rather than being sold in the open market. Following these transactions, Oei directly held 962 shares of common stock and retained derivative holdings representing 384 underlying shares through remaining restricted stock units. Additional RSU grants on June 5, 2026 added new time-based awards that vest between 2027 and 2029.

Rhea-AI Summary

BlueLinx Holdings Inc. VP & Chief Accounting Officer Kimberly Ann DeBrock reported routine equity compensation activity. On June 5, 2026, she received a grant of 2,650 time-based restricted stock units, each representing a contingent right to one share of common stock.

On June 6, 2026, 641 restricted stock units vested and converted into common stock, and on June 7, 2026, a further 214 units vested and converted. To cover tax withholding obligations, 184 shares were withheld on June 6 and 62 shares were withheld on June 7 at a price of $50.30 per share, with no open-market sales.

Following these transactions, DeBrock holds 1,086 shares of BlueLinx common stock directly. She also retains unvested restricted stock units, including awards covering 232 and 349 underlying common shares, along with the new 2,650-unit grant that will vest in future installments.

Rhea-AI Summary

BlueLinx Holdings Inc. SVP, CFO and Treasurer Christopher K. Wall reported routine equity compensation activity. On June 6, 2026, 1,778 time-based restricted stock units vested and converted into an equal number of common shares, and 792 shares were withheld to cover tax obligations, leaving him with 9,395 common shares held directly.

Wall also received new time-based restricted stock unit awards of 5,519, 1,840 and 7,359 units that vest in future years, with delivery of shares within 30 days after each vesting date. He continues to hold 3,575 unvested restricted stock units, each representing a right to receive one share of common stock.

Rhea-AI Summary

BlueLinx Holdings Inc. President and CEO Shyam K. Reddy reported equity compensation activity and related tax withholding. On June 6-7, 2026, he exercised or converted a total of 19,190 time-based restricted stock and restricted stock units into common stock, reflecting scheduled vesting.

Across those vesting events, 8,659, 5,411 and 5,120 time-based restricted stock units vested, each in three equal annual installments, and an aggregate 8,549 common shares were withheld at $50.30 per share to cover tax obligations. In addition, he received new time-based restricted stock unit awards of 29,821, 9,941 and 39,761 units, which are scheduled to vest in installments or on specific future dates, with delivery of shares within 30 days after each vesting date.

Rhea-AI Summary

BlueLinx Holdings Inc. senior vice president, CFO and treasurer Christopher K. Wall reported compensation-related equity activity involving restricted stock units and common shares.

On May 19, 2026, he exercised restricted stock units covering 1,788 shares of common stock. To satisfy tax obligations, 529 shares of common stock were withheld at $46.86 per share. After these transactions, he directly held 8,409 shares of common stock, along with time-based restricted stock units that vest ratably over three years commencing on May 19, 2026 and June 6, 2026.

Rhea-AI Summary

BlueLinx Holdings Inc. director Marietta Edmunds Zakas reported routine equity compensation activity. On May 18, 2026, she received a grant of 2,749 restricted stock units (RSUs), each representing a contingent right to one share of common stock, vesting on the first anniversary of the grant date.

On May 19, 2026, 2,074 RSUs vested and were converted into the same number of common shares, increasing her direct common stock holdings to 5,965 shares. Vested shares from both awards are scheduled to be delivered to her within 30 days after their respective vesting dates. After these transactions, she holds both common shares and an outstanding RSU award, reflecting standard director compensation rather than open-market trading.

Rhea-AI Summary

BlueLinx Holdings Inc. director Carol B. Yancey reported compensation-related equity activity. On May 19, 2026, 2,074 restricted stock units vested and converted into the same number of common shares, increasing her direct common stock holdings to 9,517 shares. The filing notes that vested shares will be delivered to her within 30 days of vesting.

On May 18, 2026, she also received a grant of 2,749 restricted stock units, each representing a contingent right to one share of common stock, which vest on the first anniversary of the grant date. These transactions reflect routine director equity compensation and do not involve any open-market buying or selling.

Rhea-AI Summary

BlueLinx Holdings Inc. director J. David Smith reported compensation-related equity activity rather than open-market trading. On May 19, 2026, he exercised 2,074 restricted stock units into an equal number of common shares, bringing his directly held common stock to 16,517 shares. Footnotes state these vested shares will be delivered to him within 30 days after the vesting date.

On May 18, 2026, he also received a grant of 2,749 restricted stock units, each representing a contingent right to one share of common stock. Separate holding entries show multiple vested RSU awards that will be delivered within 30 days after specified future dates or upon the earlier end of his Board service, highlighting that a substantial portion of his position remains in deferred stock units.

Rhea-AI Summary

BlueLinx Holdings Inc. director Lewis B. Mitchell reported equity compensation activity and a vesting event. On May 19, 2026, 2,074 restricted stock units vested and were converted into the same number of shares of Common Stock, increasing his directly held shares to 38,451. The filing notes that vested shares will be delivered to him within 30 days of vesting.

Separately, on May 18, 2026, Mitchell received a grant of 2,749 restricted stock units, each representing a contingent right to one common share. These RSUs vest on the first anniversary of the grant date, with shares to be delivered within 30 days after vesting.

Rhea-AI Summary

BlueLinx Holdings Inc. director Keith Haas reported routine equity compensation activity involving restricted stock units (RSUs). On May 19, 2026, 2,074 RSUs vested and were converted into the same number of common shares, bringing his directly held common stock to 5,965 shares.

Separately, on May 18, 2026, he received a new grant of 2,749 RSUs, each representing a contingent right to one share of common stock. These RSUs vest on the first anniversary of the grant date, with vested shares to be delivered within 30 days after vesting.

Rhea-AI Summary

BlueLinx Holdings Inc. director Kim S. Fennebresque reported equity compensation activity. On May 19, 2026, he exercised 3,218 restricted stock units into 3,218 shares of common stock at an exercise price of $0.0000 per share, bringing his direct common stock holdings to 12,982 shares.

On May 18, 2026, he also received a grant of 4,266 restricted stock units, each representing a contingent right to one common share. In addition to his direct holdings, a grantor trust holds 34,138 shares of common stock and several blocks of restricted stock units covering 22,253, 15,108, 9,485 and 21,334 underlying common shares, with delivery generally tied to vesting and specified future dates or board service termination.

Rhea-AI Summary

BlueLinx Holdings Inc. director Anuj Dhanda reported equity compensation activity involving restricted stock units (RSUs). On May 19, 2026, 2,074 RSUs vested and were converted into the same number of shares of common stock, increasing his direct holdings to 4,975 common shares. Separately, on May 18, 2026, he received a grant of 2,749 RSUs, each representing a contingent right to one share of common stock. The RSUs vest on the first anniversary of the grant date, with vested shares to be delivered within 30 days of vesting. These are compensation-related awards and conversions, with no open-market purchases or sales disclosed.

Rhea-AI Summary

BlueLinx Holdings Inc. director Christina M. Corley reported compensation-related equity activity. On May 18, 2026, she received 2,749 Restricted Stock Units (RSUs), each representing a contingent right to one share of common stock that vests on the first anniversary of grant.

On May 19, 2026, 1,297 RSUs vested and were converted into 1,297 shares of common stock, reflecting an exercise or conversion of a derivative security at a price of $0.00 per unit. After these transactions, she directly holds 1,297 shares of common stock, with delivery of vested shares to occur no later than 30 days after the respective vesting dates.

Rhea-AI Summary

BlueLinx (BXC) reported an insider equity update by its VP & Chief Accounting Officer, Kimberly Ann DeBrock. On October 18, 2025, 232 restricted stock units (RSUs) vested and were converted to common stock, and 69 shares were withheld at $70.15 to cover taxes. Direct common stock holdings stand at 477 shares after these transactions.

Outstanding RSUs listed include 1,921, 349, and 428 units, with time‑based vesting schedules that commence on June 7, 2025, in three equal annual installments commencing on June 6, 2026, and a tranche vesting on June 6, 2028.